Product Code:210626
Published Date: Jan 05,2022
Pages: 116
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
As the global economy mends, the 2021 growth of Eye Drug will have significant change from previous year. According to our (LP Information) latest study, the global Eye Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Eye Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period. The United States Eye Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Eye Drug market, reaching US$ million by the year 2028. As for the Europe Eye Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period. Global main Eye Drug players cover Pfizer, Novartis, bausch Lomb, and Laboratoire Riva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021. This report presents a comprehensive overview, market shares, and growth opportunities of Eye Drug market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6 Drops Tablet & Capsule Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7. Glaucoma Retinal Disease Bacterial?Infection Other This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include Pfizer Novartis bausch Lomb Laboratoire Riva Jamp Pharma Fresenius Teva Pharmaceutical? SANDOZ Greenstone Mylan GE Medical Mint Pharmaceuticals Laboratoires Thea Taj Pharmaceuticals Actavis APOTEX Sun Pharma
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eye Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Eye Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Eye Drug by Country/Region, 2017, 2022 & 2028
2.2 Eye Drug Segment by Type
2.2.1 Drops
2.2.2 Tablet & Capsule
2.3 Eye Drug Sales by Type
2.3.1 Global Eye Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Eye Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Eye Drug Sale Price by Type (2017-2022)
2.4 Eye Drug Segment by Application
2.4.1 Glaucoma
2.4.2 Retinal Disease
2.4.3 Bacterial?Infection
2.4.4 Other
2.5 Eye Drug Sales by Application
2.5.1 Global Eye Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Eye Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Eye Drug Sale Price by Application (2017-2022)
3 Global Eye Drug by Company
3.1 Global Eye Drug Breakdown Data by Company
3.1.1 Global Eye Drug Annual Sales by Company (2020-2022)
3.1.2 Global Eye Drug Sales Market Share by Company (2020-2022)
3.2 Global Eye Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Eye Drug Revenue by Company (2020-2022)
3.2.2 Global Eye Drug Revenue Market Share by Company (2020-2022)
3.3 Global Eye Drug Sale Price by Company
3.4 Key Manufacturers Eye Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Drug Product Location Distribution
3.4.2 Players Eye Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Eye Drug by Geographic Region
4.1 World Historic Eye Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Eye Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Eye Drug Annual Revenue by Geographic Region
4.2 World Historic Eye Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Eye Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Eye Drug Annual Revenue by Country/Region
4.3 Americas Eye Drug Sales Growth
4.4 APAC Eye Drug Sales Growth
4.5 Europe Eye Drug Sales Growth
4.6 Middle East & Africa Eye Drug Sales Growth
5 Americas
5.1 Americas Eye Drug Sales by Country
5.1.1 Americas Eye Drug Sales by Country (2017-2022)
5.1.2 Americas Eye Drug Revenue by Country (2017-2022)
5.2 Americas Eye Drug Sales by Type
5.3 Americas Eye Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Drug Sales by Region
6.1.1 APAC Eye Drug Sales by Region (2017-2022)
6.1.2 APAC Eye Drug Revenue by Region (2017-2022)
6.2 APAC Eye Drug Sales by Type
6.3 APAC Eye Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eye Drug by Country
7.1.1 Europe Eye Drug Sales by Country (2017-2022)
7.1.2 Europe Eye Drug Revenue by Country (2017-2022)
7.2 Europe Eye Drug Sales by Type
7.3 Europe Eye Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eye Drug by Country
8.1.1 Middle East & Africa Eye Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Eye Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Eye Drug Sales by Type
8.3 Middle East & Africa Eye Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Drug
10.3 Manufacturing Process Analysis of Eye Drug
10.4 Industry Chain Structure of Eye Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Drug Distributors
11.3 Eye Drug Customer
12 World Forecast Review for Eye Drug by Geographic Region
12.1 Global Eye Drug Market Size Forecast by Region
12.1.1 Global Eye Drug Forecast by Region (2023-2028)
12.1.2 Global Eye Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eye Drug Forecast by Type
12.7 Global Eye Drug Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Eye Drug Product Offered
13.1.3 Pfizer Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Eye Drug Product Offered
13.2.3 Novartis Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 bausch Lomb
13.3.1 bausch Lomb Company Information
13.3.2 bausch Lomb Eye Drug Product Offered
13.3.3 bausch Lomb Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 bausch Lomb Main Business Overview
13.3.5 bausch Lomb Latest Developments
13.4 Laboratoire Riva
13.4.1 Laboratoire Riva Company Information
13.4.2 Laboratoire Riva Eye Drug Product Offered
13.4.3 Laboratoire Riva Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Laboratoire Riva Main Business Overview
13.4.5 Laboratoire Riva Latest Developments
13.5 Jamp Pharma
13.5.1 Jamp Pharma Company Information
13.5.2 Jamp Pharma Eye Drug Product Offered
13.5.3 Jamp Pharma Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Jamp Pharma Main Business Overview
13.5.5 Jamp Pharma Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Eye Drug Product Offered
13.6.3 Fresenius Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Teva Pharmaceutical?
13.7.1 Teva Pharmaceutical? Company Information
13.7.2 Teva Pharmaceutical? Eye Drug Product Offered
13.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Teva Pharmaceutical? Main Business Overview
13.7.5 Teva Pharmaceutical? Latest Developments
13.8 SANDOZ
13.8.1 SANDOZ Company Information
13.8.2 SANDOZ Eye Drug Product Offered
13.8.3 SANDOZ Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 SANDOZ Main Business Overview
13.8.5 SANDOZ Latest Developments
13.9 Greenstone
13.9.1 Greenstone Company Information
13.9.2 Greenstone Eye Drug Product Offered
13.9.3 Greenstone Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Greenstone Main Business Overview
13.9.5 Greenstone Latest Developments
13.10 Mylan
13.10.1 Mylan Company Information
13.10.2 Mylan Eye Drug Product Offered
13.10.3 Mylan Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mylan Main Business Overview
13.10.5 Mylan Latest Developments
13.11 GE Medical
13.11.1 GE Medical Company Information
13.11.2 GE Medical Eye Drug Product Offered
13.11.3 GE Medical Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 GE Medical Main Business Overview
13.11.5 GE Medical Latest Developments
13.12 Mint Pharmaceuticals
13.12.1 Mint Pharmaceuticals Company Information
13.12.2 Mint Pharmaceuticals Eye Drug Product Offered
13.12.3 Mint Pharmaceuticals Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Mint Pharmaceuticals Main Business Overview
13.12.5 Mint Pharmaceuticals Latest Developments
13.13 Laboratoires Thea
13.13.1 Laboratoires Thea Company Information
13.13.2 Laboratoires Thea Eye Drug Product Offered
13.13.3 Laboratoires Thea Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Laboratoires Thea Main Business Overview
13.13.5 Laboratoires Thea Latest Developments
13.14 Taj Pharmaceuticals
13.14.1 Taj Pharmaceuticals Company Information
13.14.2 Taj Pharmaceuticals Eye Drug Product Offered
13.14.3 Taj Pharmaceuticals Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Taj Pharmaceuticals Main Business Overview
13.14.5 Taj Pharmaceuticals Latest Developments
13.15 Actavis
13.15.1 Actavis Company Information
13.15.2 Actavis Eye Drug Product Offered
13.15.3 Actavis Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Actavis Main Business Overview
13.15.5 Actavis Latest Developments
13.16 APOTEX
13.16.1 APOTEX Company Information
13.16.2 APOTEX Eye Drug Product Offered
13.16.3 APOTEX Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 APOTEX Main Business Overview
13.16.5 APOTEX Latest Developments
13.17 Sun Pharma
13.17.1 Sun Pharma Company Information
13.17.2 Sun Pharma Eye Drug Product Offered
13.17.3 Sun Pharma Eye Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sun Pharma Main Business Overview
13.17.5 Sun Pharma Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Eye Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Eye Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of Drops Table 4. Major Players of Tablet & Capsule Table 5. Global Eye Drug Sales by Type (2017-2022) & (MT) Table 6. Global Eye Drug Sales Market Share by Type (2017-2022) Table 7. Global Eye Drug Revenue by Type (2017-2022) & ($ million) Table 8. Global Eye Drug Revenue Market Share by Type (2017-2022) Table 9. Global Eye Drug Sale Price by Type (2017-2022) & (USD/Kg) Table 10. Global Eye Drug Sales by Application (2017-2022) & (MT) Table 11. Global Eye Drug Sales Market Share by Application (2017-2022) Table 12. Global Eye Drug Revenue by Application (2017-2022) Table 13. Global Eye Drug Revenue Market Share by Application (2017-2022) Table 14. Global Eye Drug Sale Price by Application (2017-2022) & (USD/Kg) Table 15. Global Eye Drug Sales by Company (2020-2022) & (MT) Table 16. Global Eye Drug Sales Market Share by Company (2020-2022) Table 17. Global Eye Drug Revenue by Company (2020-2022) ($ Millions) Table 18. Global Eye Drug Revenue Market Share by Company (2020-2022) Table 19. Global Eye Drug Sale Price by Company (2020-2022) & (USD/Kg) Table 20. Key Manufacturers Eye Drug Producing Area Distribution and Sales Area Table 21. Players Eye Drug Products Offered Table 22. Eye Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Eye Drug Sales by Geographic Region (2017-2022) & (MT) Table 26. Global Eye Drug Sales Market Share Geographic Region (2017-2022) Table 27. Global Eye Drug Revenue by Geographic Region (2017-2022) & ($ millions) Table 28. Global Eye Drug Revenue Market Share by Geographic Region (2017-2022) Table 29. Global Eye Drug Sales by Country/Region (2017-2022) & (MT) Table 30. Global Eye Drug Sales Market Share by Country/Region (2017-2022) Table 31. Global Eye Drug Revenue by Country/Region (2017-2022) & ($ millions) Table 32. Global Eye Drug Revenue Market Share by Country/Region (2017-2022) Table 33. Americas Eye Drug Sales by Country (2017-2022) & (MT) Table 34. Americas Eye Drug Sales Market Share by Country (2017-2022) Table 35. Americas Eye Drug Revenue by Country (2017-2022) & ($ Millions) Table 36. Americas Eye Drug Revenue Market Share by Country (2017-2022) Table 37. Americas Eye Drug Sales by Type (2017-2022) & (MT) Table 38. Americas Eye Drug Sales Market Share by Type (2017-2022) Table 39. Americas Eye Drug Sales by Application (2017-2022) & (MT) Table 40. Americas Eye Drug Sales Market Share by Application (2017-2022) Table 41. APAC Eye Drug Sales by Region (2017-2022) & (MT) Table 42. APAC Eye Drug Sales Market Share by Region (2017-2022) Table 43. APAC Eye Drug Revenue by Region (2017-2022) & ($ Millions) Table 44. APAC Eye Drug Revenue Market Share by Region (2017-2022) Table 45. APAC Eye Drug Sales by Type (2017-2022) & (MT) Table 46. APAC Eye Drug Sales Market Share by Type (2017-2022) Table 47. APAC Eye Drug Sales by Application (2017-2022) & (MT) Table 48. APAC Eye Drug Sales Market Share by Application (2017-2022) Table 49. Europe Eye Drug Sales by Country (2017-2022) & (MT) Table 50. Europe Eye Drug Sales Market Share by Country (2017-2022) Table 51. Europe Eye Drug Revenue by Country (2017-2022) & ($ Millions) Table 52. Europe Eye Drug Revenue Market Share by Country (2017-2022) Table 53. Europe Eye Drug Sales by Type (2017-2022) & (MT) Table 54. Europe Eye Drug Sales Market Share by Type (2017-2022) Table 55. Europe Eye Drug Sales by Application (2017-2022) & (MT) Table 56. Europe Eye Drug Sales Market Share by Application (2017-2022) Table 57. Middle East & Africa Eye Drug Sales by Country (2017-2022) & (MT) Table 58. Middle East & Africa Eye Drug Sales Market Share by Country (2017-2022) Table 59. Middle East & Africa Eye Drug Revenue by Country (2017-2022) & ($ Millions) Table 60. Middle East & Africa Eye Drug Revenue Market Share by Country (2017-2022) Table 61. Middle East & Africa Eye Drug Sales by Type (2017-2022) & (MT) Table 62. Middle East & Africa Eye Drug Sales Market Share by Type (2017-2022) Table 63. Middle East & Africa Eye Drug Sales by Application (2017-2022) & (MT) Table 64. Middle East & Africa Eye Drug Sales Market Share by Application (2017-2022) Table 65. Key Market Drivers & Growth Opportunities of Eye Drug Table 66. Key Market Challenges & Risks of Eye Drug Table 67. Key Industry Trends of Eye Drug Table 68. Eye Drug Raw Material Table 69. Key Suppliers of Raw Materials Table 70. Eye Drug Distributors List Table 71. Eye Drug Customer List Table 72. Global Eye Drug Sales Forecast by Region (2023-2028) & (MT) Table 73. Global Eye Drug Sales Market Forecast by Region Table 74. Global Eye Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 75. Global Eye Drug Revenue Market Share Forecast by Region (2023-2028) Table 76. Americas Eye Drug Sales Forecast by Country (2023-2028) & (MT) Table 77. Americas Eye Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 78. APAC Eye Drug Sales Forecast by Region (2023-2028) & (MT) Table 79. APAC Eye Drug Revenue Forecast by Region (2023-2028) & ($ millions) Table 80. Europe Eye Drug Sales Forecast by Country (2023-2028) & (MT) Table 81. Europe Eye Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. Middle East & Africa Eye Drug Sales Forecast by Country (2023-2028) & (MT) Table 83. Middle East & Africa Eye Drug Revenue Forecast by Country (2023-2028) & ($ millions) Table 84. Global Eye Drug Sales Forecast by Type (2023-2028) & (MT) Table 85. Global Eye Drug Sales Market Share Forecast by Type (2023-2028) Table 86. Global Eye Drug Revenue Forecast by Type (2023-2028) & ($ Millions) Table 87. Global Eye Drug Revenue Market Share Forecast by Type (2023-2028) Table 88. Global Eye Drug Sales Forecast by Application (2023-2028) & (MT) Table 89. Global Eye Drug Sales Market Share Forecast by Application (2023-2028) Table 90. Global Eye Drug Revenue Forecast by Application (2023-2028) & ($ Millions) Table 91. Global Eye Drug Revenue Market Share Forecast by Application (2023-2028) Table 92. Pfizer Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 93. Pfizer Eye Drug Product Offered Table 94. Pfizer Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 95. Pfizer Main Business Table 96. Pfizer Latest Developments Table 97. Novartis Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 98. Novartis Eye Drug Product Offered Table 99. Novartis Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 100. Novartis Main Business Table 101. Novartis Latest Developments Table 102. bausch Lomb Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 103. bausch Lomb Eye Drug Product Offered Table 104. bausch Lomb Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 105. bausch Lomb Main Business Table 106. bausch Lomb Latest Developments Table 107. Laboratoire Riva Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 108. Laboratoire Riva Eye Drug Product Offered Table 109. Laboratoire Riva Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 110. Laboratoire Riva Main Business Table 111. Laboratoire Riva Latest Developments Table 112. Jamp Pharma Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 113. Jamp Pharma Eye Drug Product Offered Table 114. Jamp Pharma Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 115. Jamp Pharma Main Business Table 116. Jamp Pharma Latest Developments Table 117. Fresenius Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 118. Fresenius Eye Drug Product Offered Table 119. Fresenius Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 120. Fresenius Main Business Table 121. Fresenius Latest Developments Table 122. Teva Pharmaceutical? Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 123. Teva Pharmaceutical? Eye Drug Product Offered Table 124. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 125. Teva Pharmaceutical? Main Business Table 126. Teva Pharmaceutical? Latest Developments Table 127. SANDOZ Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 128. SANDOZ Eye Drug Product Offered Table 129. SANDOZ Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 130. SANDOZ Main Business Table 131. SANDOZ Latest Developments Table 132. Greenstone Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 133. Greenstone Eye Drug Product Offered Table 134. Greenstone Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 135. Greenstone Main Business Table 136. Greenstone Latest Developments Table 137. Mylan Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 138. Mylan Eye Drug Product Offered Table 139. Mylan Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 140. Mylan Main Business Table 141. Mylan Latest Developments Table 142. GE Medical Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 143. GE Medical Eye Drug Product Offered Table 144. GE Medical Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 145. GE Medical Main Business Table 146. GE Medical Latest Developments Table 147. Mint Pharmaceuticals Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 148. Mint Pharmaceuticals Eye Drug Product Offered Table 149. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 150. Mint Pharmaceuticals Main Business Table 151. Mint Pharmaceuticals Latest Developments Table 152. Laboratoires Thea Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 153. Laboratoires Thea Eye Drug Product Offered Table 154. Laboratoires Thea Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 155. Laboratoires Thea Main Business Table 156. Laboratoires Thea Latest Developments Table 157. Taj Pharmaceuticals Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 158. Taj Pharmaceuticals Eye Drug Product Offered Table 159. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 160. Taj Pharmaceuticals Main Business Table 161. Taj Pharmaceuticals Latest Developments Table 162. Actavis Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 163. Actavis Eye Drug Product Offered Table 164. Actavis Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 165. Actavis Main Business Table 166. Actavis Latest Developments Table 167. APOTEX Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 168. APOTEX Eye Drug Product Offered Table 169. APOTEX Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 170. APOTEX Main Business Table 171. APOTEX Latest Developments Table 172. Sun Pharma Basic Information, Eye Drug Manufacturing Base, Sales Area and Its Competitors Table 173. Sun Pharma Eye Drug Product Offered Table 174. Sun Pharma Eye Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022) Table 175. Sun Pharma Main Business Table 176. Sun Pharma Latest Developments List of Figures Figure 1. Picture of Eye Drug Figure 2. Eye Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Eye Drug Sales Growth Rate 2017-2028 (MT) Figure 7. Global Eye Drug Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Eye Drug Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of Drops Figure 10. Product Picture of Tablet & Capsule Figure 11. Global Eye Drug Sales Market Share by Type in 2021 Figure 12. Global Eye Drug Revenue Market Share by Type (2017-2022) Figure 13. Eye Drug Consumed in Glaucoma Figure 14. Global Eye Drug Market: Glaucoma (2017-2022) & (MT) Figure 15. Eye Drug Consumed in Retinal Disease Figure 16. Global Eye Drug Market: Retinal Disease (2017-2022) & (MT) Figure 17. Eye Drug Consumed in Bacterial?Infection Figure 18. Global Eye Drug Market: Bacterial?Infection (2017-2022) & (MT) Figure 19. Eye Drug Consumed in Other Figure 20. Global Eye Drug Market: Other (2017-2022) & (MT) Figure 21. Global Eye Drug Sales Market Share by Application (2017-2022) Figure 22. Global Eye Drug Revenue Market Share by Application in 2021 Figure 23. Eye Drug Revenue Market by Company in 2021 ($ Million) Figure 24. Global Eye Drug Revenue Market Share by Company in 2021 Figure 25. Global Eye Drug Sales Market Share by Geographic Region (2017-2022) Figure 26. Global Eye Drug Revenue Market Share by Geographic Region in 2021 Figure 27. Global Eye Drug Sales Market Share by Region (2017-2022) Figure 28. Global Eye Drug Revenue Market Share by Country/Region in 2021 Figure 29. Americas Eye Drug Sales 2017-2022 (MT) Figure 30. Americas Eye Drug Revenue 2017-2022 ($ Millions) Figure 31. APAC Eye Drug Sales 2017-2022 (MT) Figure 32. APAC Eye Drug Revenue 2017-2022 ($ Millions) Figure 33. Europe Eye Drug Sales 2017-2022 (MT) Figure 34. Europe Eye Drug Revenue 2017-2022 ($ Millions) Figure 35. Middle East & Africa Eye Drug Sales 2017-2022 (MT) Figure 36. Middle East & Africa Eye Drug Revenue 2017-2022 ($ Millions) Figure 37. Americas Eye Drug Sales Market Share by Country in 2021 Figure 38. Americas Eye Drug Revenue Market Share by Country in 2021 Figure 39. United States Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 40. Canada Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 41. Mexico Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 42. Brazil Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 43. APAC Eye Drug Sales Market Share by Region in 2021 Figure 44. APAC Eye Drug Revenue Market Share by Regions in 2021 Figure 45. China Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 46. Japan Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 47. South Korea Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 48. Southeast Asia Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 49. India Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 50. Australia Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 51. Europe Eye Drug Sales Market Share by Country in 2021 Figure 52. Europe Eye Drug Revenue Market Share by Country in 2021 Figure 53. Germany Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 54. France Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 55. UK Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 56. Italy Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 57. Russia Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 58. Middle East & Africa Eye Drug Sales Market Share by Country in 2021 Figure 59. Middle East & Africa Eye Drug Revenue Market Share by Country in 2021 Figure 60. Egypt Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 61. South Africa Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 62. Israel Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 63. Turkey Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 64. GCC Country Eye Drug Revenue Growth 2017-2022 ($ Millions) Figure 65. Manufacturing Cost Structure Analysis of Eye Drug in 2021 Figure 66. Manufacturing Process Analysis of Eye Drug Figure 67. Industry Chain Structure of Eye Drug Figure 68. Channels of Distribution Figure 69. Distributors Profiles
Pfizer Novartis bausch Lomb Laboratoire Riva Jamp Pharma Fresenius Teva Pharmaceutical? SANDOZ Greenstone Mylan GE Medical Mint Pharmaceuticals Laboratoires Thea Taj Pharmaceuticals Actavis APOTEX Sun Pharma
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape